Clinical Trials Browser

Phase 2 × Active not recruiting × HR+/HER2- Breast Cancer × Clear all

NCT07130643 2025-08-19

Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer

Phase 2 Active not recruiting

HR+/HER2- Breast Cancer